Mailloux R J, DeLegge M H, Kirby D F
Division of Gastroenterology and Nutrition, Medical College of Virginia, Richmond.
JPEN J Parenter Enteral Nutr. 1993 Nov-Dec;17(6):578-82. doi: 10.1177/0148607193017006578.
Although much has been written concerning the complications of long-term total parenteral nutrition, little or no mention of pulmonary embolism is made in the literature. We present two patients maintained on home total parenteral nutrition who suffered pulmonary emboli, one while receiving standard heparin therapy. No potential source other than their indwelling total parenteral nutrition catheter was identified. Studies have revealed catheter-related thrombosis in up to 50% of patients with indwelling central venous catheters. Although early surgical literature suggested that upper extremity deep vein thromboses rarely embolize, more recent investigations have proven this false. In fact, the risk of pulmonary emboli appeared to be greatest in those thrombi that were catheter related. Because of this risk, we suggest a hypercoaguable work-up in any patient with a history of recurrent thrombosis. Heparin is central to the current preventive regimens; however, further study is needed to determine the most efficacious dose. Future development of less thrombogenic catheters will also be of assistance. Thrombolytic agents currently have an expanding role in the treatment of thrombotic complications. Whether they will have a future role in prevention remains unknown.
尽管已有大量关于长期全胃肠外营养并发症的文献报道,但其中很少提及或根本没有提及肺栓塞。我们报告两例接受家庭全胃肠外营养治疗的患者发生了肺栓塞,其中一例在接受标准肝素治疗时发病。除了留置的全胃肠外营养导管外,未发现其他潜在的栓子来源。研究表明,在留置中心静脉导管的患者中,高达50%会发生与导管相关的血栓形成。尽管早期的外科文献表明上肢深静脉血栓很少发生栓塞,但最近的研究证明这种说法是错误的。事实上,与导管相关的血栓发生肺栓塞的风险似乎最大。鉴于这种风险,我们建议对任何有复发性血栓形成病史的患者进行高凝状态检查。肝素是目前预防方案的核心药物;然而,需要进一步研究以确定最有效的剂量。未来开发血栓形成性更低的导管也将有所帮助。溶栓药物目前在血栓形成并发症的治疗中发挥着越来越大的作用。它们在预防方面是否会有未来作用仍不清楚。